[Dystonias].
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004422:Dystonia Musculorum Deformans; D005116:Extrapyramidal Tracts; D005260:Female; D006527:Hepatolenticular Degeneration / Q000150:complications; D006801:Humans; D006816:Huntington Disease / Q000150:complications; D008297:Male; D009069:Movement Disorders / Q000188:drug therapy / Q000209:etiology; D009120:Muscle Cramp; D018377:Neurotransmitter Agents / Q000627:therapeutic use; D006211:Pantothenate Kinase-Associated Neurodegeneration / Q000150:complications; D010300:Parkinson Disease / Q000150:complications; D012701:Serotonin / Q000627:therapeutic use
D018377:Neurotransmitter Agents; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan
Les dystonies.